Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NYBOLIG JAN MILVERTZ A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.1%   Bankruptcy risk   1.0% 1.4% 0.8% 0.8% 1.0% 2.1% 10.9% 8.4%   Credit score (0-100)   89 79 93 90 85 66 21 29   Credit rating   A A AA A A A BB BB   Credit limit (kDKK)   535.3 34.9 798.7 1,001.0 511.9 0.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   11,186 9,197 11,173 12,252 5,725 -13.1 0.0 0.0   EBITDA   3,158 1,436 3,364 5,666 2,024 -345 0.0 0.0   EBIT   3,042 1,311 3,166 5,509 1,950 -345 0.0 0.0   Pre-tax profit (PTP)   3,282.2 1,639.0 3,536.6 6,059.4 4,287.1 1,375.3 0.0 0.0   Net earnings   2,557.2 1,270.4 2,754.3 4,724.5 3,706.0 1,362.2 0.0 0.0   Pre-tax profit without non-rec. items   3,282 1,639 3,537 6,059 4,287 1,375 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   226 634 381 269 179 0.0 0.0 0.0   Shareholders equity total   4,823 3,093 5,847 7,572 7,278 5,640 4,640 4,640   Interest-bearing liabilities   2,365 3,602 1,950 1,624 3,832 6.7 0.0 0.0   Balance sheet total (assets)   11,695 9,961 12,151 15,969 14,047 5,811 4,640 4,640   Net Debt   1,964 3,428 1,879 1,221 3,734 6.7 -4,640 -4,640     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   11,186 9,197 11,173 12,252 5,725 -13.1 0.0 0.0   Gross profit growth   20.3% -17.8% 21.5% 9.7% -53.3% 0.0% 0.0% 0.0%   Employees   15 15 15 15 7 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% -53.3% -100.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   11,695 9,961 12,151 15,969 14,047 5,811 4,640 4,640   Balance sheet change%   29.9% -14.8% 22.0% 31.4% -12.0% -58.6% -20.2% 0.0%   Added value   3,041.7 1,311.2 3,166.0 5,508.8 1,950.4 -345.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -169 283 -451 -269 -164 -179 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 -1.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   27.2% 14.3% 28.3% 45.0% 34.1% 2,628.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   32.4% 16.5% 32.7% 43.6% 29.0% 14.9% 0.0% 0.0%   ROI %   53.3% 25.7% 49.5% 71.1% 42.5% 17.6% 0.0% 0.0%   ROE %   56.3% 32.1% 61.6% 70.4% 49.9% 21.1% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   41.6% 31.1% 48.3% 47.4% 51.8% 97.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   62.2% 238.7% 55.8% 21.5% 184.5% -1.9% 0.0% 0.0%   Gearing %   49.0% 116.5% 33.3% 21.4% 52.7% 0.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.0% 5.0% 2.9% 3.9% 2.4% 5.6% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   1.7 1.4 1.9 1.9 2.1 30.8 0.0 0.0   Current Ratio   1.7 1.4 1.9 1.9 2.1 30.8 0.0 0.0   Cash and cash equivalent   400.8 173.5 71.3 403.0 97.8 0.0 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   4,564.7 2,426.8 5,556.7 7,393.3 7,111.3 5,088.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   203 87 211 367 279 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   211 96 224 378 289 0 0 0   EBIT / employee   203 87 211 367 279 0 0 0   Net earnings / employee   170 85 184 315 529 0 0 0